Goodwill in USD of STANDARD BIOTOOLS INC. from Q4 2013 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
Standard Biotools Inc. quarterly Goodwill history and change rate from Q4 2013 to Q1 2025.
  • Standard Biotools Inc. Goodwill for the quarter ending 31 Mar 2025 was $112M, a 5.13% increase year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Change (%)

STANDARD BIOTOOLS INC. Quarterly Goodwill (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $112M +$5.45M +5.13% 31 Mar 2025 10-Q 06 May 2025
Q4 2024 $111M +$4.98M +4.68% 31 Dec 2024 10-Q 06 May 2025
Q3 2024 $106M +$117K +0.11% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $106M -$34K -0.03% 30 Jun 2024 10-Q 06 Aug 2024
Q1 2024 $106M -$16K -0.02% 31 Mar 2024 10-Q 09 May 2024
Q4 2023 $106M +$66K +0.06% 31 Dec 2023 10-K 11 Mar 2025
Q3 2023 $106M +$156K +0.15% 30 Sep 2023 10-Q 07 Nov 2023
Q2 2023 $106M +$87K +0.08% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $106M -$48K -0.05% 31 Mar 2023 10-Q 09 May 2023
Q4 2022 $106M -$128K -0.12% 31 Dec 2022 10-K 11 Mar 2025
Q3 2022 $106M -$359K -0.34% 30 Sep 2022 10-Q 09 Nov 2022
Q2 2022 $106M -$286K -0.27% 30 Jun 2022 10-Q 09 Aug 2022
Q1 2022 $106M -$123K -0.12% 31 Mar 2022 10-Q 09 May 2022
Q4 2021 $106M -$184K -0.17% 31 Dec 2021 10-K 11 Mar 2025
Q3 2021 $106M -$27K -0.03% 30 Sep 2021 10-Q 09 Nov 2021
Q2 2021 $106M +$158K +0.15% 30 Jun 2021 10-Q 06 Aug 2021
Q1 2021 $106M +$128K +0.12% 31 Mar 2021 10-Q 07 May 2021
Q4 2020 $107M +$2.46M +2.36% 31 Dec 2020 10-K 08 Mar 2022
Q3 2020 $106M +$2.35M +2.25% 30 Sep 2020 10-Q 09 Nov 2020
Q2 2020 $106M +$2.22M +2.13% 30 Jun 2020 10-Q 07 Aug 2020
Q1 2020 $106M +$2.22M +2.13% 31 Mar 2020 10-Q 11 May 2020
Q4 2019 $104M $0 0% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $104M $0 0% 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $104M $0 0% 30 Jun 2019 10-Q 07 Aug 2019
Q1 2019 $104M $0 0% 31 Mar 2019 10-Q 07 May 2019
Q4 2018 $104M $0 0% 31 Dec 2018 10-K 27 Feb 2020
Q3 2018 $104M $0 0% 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $104M $0 0% 30 Jun 2018 10-Q 08 Aug 2018
Q1 2018 $104M $0 0% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $104M $0 0% 31 Dec 2017 10-K 18 Mar 2019
Q3 2017 $104M $0 0% 30 Sep 2017 10-Q 07 Nov 2017
Q2 2017 $104M $0 0% 30 Jun 2017 10-Q 08 Aug 2017
Q1 2017 $104M $0 0% 31 Mar 2017 10-Q 09 May 2017
Q4 2016 $104M $0 0% 31 Dec 2016 10-K 08 Mar 2018
Q3 2016 $104M $0 0% 30 Sep 2016 10-Q 09 Nov 2016
Q2 2016 $104M $0 0% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $104M $0 0% 31 Mar 2016 10-Q 09 May 2016
Q4 2015 $104M $0 0% 31 Dec 2015 10-K 03 Mar 2017
Q3 2015 $104M -$137K -0.13% 30 Sep 2015 10-Q 09 Nov 2015
Q2 2015 $104M -$137K -0.13% 30 Jun 2015 10-Q 10 Aug 2015
Q1 2015 $104M -$137K -0.13% 31 Mar 2015 10-Q 11 May 2015
Q4 2014 $104M +$104M 31 Dec 2014 10-K 29 Feb 2016
Q3 2014 $104M 30 Sep 2014 10-Q 06 Nov 2014
Q2 2014 $104M 30 Jun 2014 10-Q 04 Aug 2014
Q1 2014 $104M 31 Mar 2014 10-Q 12 May 2014
Q4 2013 $0 31 Dec 2013 10-K 26 Feb 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.